Deferred Tax Assets, Valuation Allowance of Burning Rock Biotech Ltd from 31 Dec 2019 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD and CNY
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Burning Rock Biotech Ltd quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2019 to 31 Dec 2024.
  • Burning Rock Biotech Ltd Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $81,633,000, a 8.3% increase year-over-year.
Burning Rock Biotech Ltd quarterly Deferred Tax Assets, Valuation Allowance in CNY history and change rate from 31 Dec 2019 to 31 Dec 2024.
  • Burning Rock Biotech Ltd Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was ¥595,868,000, a 11% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)
Deferred Tax Assets, Valuation Allowance, Quarterly (CNY)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Burning Rock Biotech Ltd Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $81,633,000 +$6,229,000 +8.3% 31 Dec 2024 20-F 29 Apr 2025 2024 FY
Q4 2023 $75,404,000 +$12,069,000 +19% 31 Dec 2023 20-F 29 Apr 2024 2023 FY
Q4 2022 $63,335,000 +$21,877,000 +53% 31 Dec 2022 20-F 20 Apr 2023 2022 FY
Q4 2021 $41,458,000 +$15,359,000 +59% 31 Dec 2021 20-F 29 Apr 2022 2021 FY
Q4 2020 $26,099,000 31 Dec 2020 20-F 23 Mar 2021 2020 FY

Burning Rock Biotech Ltd Quarterly Deferred Tax Assets, Valuation Allowance (CNY)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 ¥595,868,000 +¥60,505,000 +11% 31 Dec 2024 20-F 29 Apr 2025 2024 FY
Q4 2023 ¥535,363,000 +¥98,530,000 +23% 31 Dec 2023 20-F 29 Apr 2025 2024 FY
Q4 2022 ¥436,833,000 +¥172,637,000 +65% 31 Dec 2022 20-F 29 Apr 2024 2023 FY
Q4 2021 ¥264,196,000 +¥93,898,000 +55% 31 Dec 2021 20-F 20 Apr 2023 2022 FY
Q4 2020 ¥170,298,000 +¥52,196,000 +44% 31 Dec 2020 20-F 29 Apr 2022 2021 FY
Q4 2019 ¥118,102,000 31 Dec 2019 20-F 23 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.